Has Zelda McIntosh received payments from drug or device companies?

Yes. Drug and device makers reported $6,144 in general payments to Zelda McIntosh across 348 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Zelda McIntosh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Zelda McIntosh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Zelda McIntosh

Family · Prestonsburg, KYNPI 1023401866

Payments from drug & device makers

$6,144in general payments, 2019–2025

Across 348 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$922
Teva Pharmaceuticals USA, Inc.$870
Johnson & Johnson$598
Lundbeck LLC$589
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$543
Vanda Pharmaceuticals Inc.$522
plus $2K from 12 others

What the payments were for

Food & beverage$6,138100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	67	$922
Teva Pharmaceuticals USA, Inc.	37	$870
Johnson & Johnson	32	$598
Lundbeck LLC	33	$589
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	38	$543
Vanda Pharmaceuticals Inc.	20	$522
Alkermes, Inc.	31	$479
Neurocrine Biosciences, Inc.	23	$452
Otsuka America Pharmaceutical, Inc.	22	$417
Indivior Inc.	20	$318
Axsome Therapeutics, Inc.	10	$186
Takeda Pharmaceuticals U.S.A., Inc.	4	$68
Corium, LLC	3	$53
Eisai Inc.	2	$32
E.r. Squibb & Sons, L.L.C.	2	$29
Supernus Pharmaceuticals, Inc.	2	$26
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$20
Braeburn Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,144 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	33	$64,363
RexultiBrexpiprazole	14	$34,258
TrintellixVortioxetine Hydrobromide	14	$12,250
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	312	$9,870
Aripiprazole	68	$8,678
ZubsolvBuprenorphine Hcl/Naloxone Hcl	27	$3,391
Chlorpromazine Hcl	11	$1,760
Mirtazapine	123	$1,695
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	30	$1,631
Quetiapine Fumarate	171	$1,464
Hydroxyzine Hcl	91	$1,383
Venlafaxine Hcl ErVenlafaxine Hcl	63	$929
Paroxetine Hcl	94	$883
Amitriptyline Hcl	61	$880
Hydroxyzine Pamoate	68	$770

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$922	$64,36333 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$417	$34,25814 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$68	$12,25014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Prestonsburg

Bonnie HillLouisa$372K
Ashley SnellenElizabethtown$190K
Smita RanjanLouisville$92K
Elizabeth SaltLexington$89K
Tracey GaslinLouisville$79K
Kassandra GreenLouisville$69K
Danielle RevertLouisville$65K
Lora BrownMonticellow$61K
Shelley WaldmanLouisville$59K
Vicki ChapmanMount Vernon$57K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →